# Akums Drugs and Pharmaceuticals Ltd (AKUMS)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹520.05
Day Change: -0.25%
52W High: ₹622.95
52W Low: ₹409.3
Market Cap: ₹7,957 Cr

## Valuation
P/E: 31.22
P/B: 2.4
EPS: ₹16.65
Book Value: ₹216.55
Dividend Yield: 0%

## Returns
1Y Return: 14.76%

## Profitability
ROE: 8.02%
ROCE: 16.82%
Debt/Equity: 0.05
Revenue Growth: 12.7%
Profit Growth: -42.6%
EBITDA Margin: 14.5%
Operating Margin: 12.31%

## About
Akums Drugs and Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Akums Drugs and Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- Announcement: Update On Disruption In Operations At Some Of The Manufacturing Sites At Haridwar
- BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance

## Access
Current tier: anonymous
More history: Register free to see 5 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.754Z
Price History Updated: 2026-05-25T05:24:18.276Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:24:18.276Z
Quant Updated: 2026-05-25T05:24:18.276Z
Sentiment Updated: 2026-05-25T05:24:18.276Z
Financials Status: current
Financials Updated: 2026-05-18T11:31:44.899Z
Financials Last Attempt: 2026-05-18T11:31:44.899Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹1464 Cr
Operating Profit: ₹124 Cr (OPM 8%)
Net Profit: ₹43 Cr
Tax: ₹77 Cr

## Annual P&L History
Mar 2016: Rev ₹1464Cr | PAT ₹43Cr | OPM 8%
Mar 2020: Rev ₹1651Cr | PAT ₹61Cr | OPM 9%
Mar 2021: Rev ₹2414Cr | PAT ₹44Cr | OPM 7%

## Balance Sheet (Mar 2016)
Total Assets: ₹1042 Cr
Total Liabilities: ₹1042 Cr
Borrowings: ₹255 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sanjeev  Jain, Co-Founder, MD & Whole Time Director
- Sandeep  Jain, Co Founder, MD & Director
- Sumeet  Sood, Chief Financial Officer
- Sanjay Kumar Sinha, President of Operations & Whole Time Director
- Dharamvir  Malik, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/akums
Disclaimer: For research and education only. Not investment advice.